Michael Carusi left the role of Director at Shoulder Innovations, Inc. As of November 14, 2026, Shoulder Innovations, Inc. has reported 2 leadership change filings to the SEC under Item 5.02 of Form 8-K, from March 2, 2026 to March 10, 2026, naming 1 appointment and 1 departure (Form 8-K, March 10, 2026).
29 companies changed executives this week, 1 had other signals.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| ONITY GROUP INC. | announced the departure of its Chief Investment Officer | |
| Adicet Bio, Inc. | announced the departure of its Director | |
| MAMMOTH ENERGY SERVICES, INC. | announced the departure of its Chief Operating Officer | |
| CERENOME, INC. | named a new Director | |
| Cohen & Co Inc. | named a new Chief Executive Officer |
Sell to companies like Shoulder Innovations, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Shoulder Innovations, Inc. reported changes in 2 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-03-02 to 2026-03-10. They name 2 people, with 1 appointment and 1 departure. Every row below is cited to the filing it comes from, and this page adds each new change as Shoulder Innovations, Inc. files it.
Also on the record for Shoulder Innovations, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| August 7, 2026 | Stake report, Schedule 13D/A, by Gilde Healthcare Holding B.V. | 10.7% of the class | 5%+ stakes | Source |
| August 6, 2026 | Stake report, Schedule 13G/A, by FMR LLC | 17.7% of the class | 5%+ stakes | Source |
| May 7, 2026 | Stake report, Schedule 13G/A, by Ball Robert Joseph | 3.6% of the class | 5%+ stakes | Source |
| November 14, 2025 | Stake report, Schedule 13G, by Casey M. Tansey | 13.3% of the class | 5%+ stakes | Source |
| November 14, 2025 | Stake report, Schedule 13G, by LSV Associates II, LLC | 9.3% of the class | 5%+ stakes | Source |
| November 12, 2025 | Stake report, Schedule 13G, by cultivate(MD) Holdings, LLC | 6.7% of the class | 5%+ stakes | Source |
| September 8, 2025 | Stake report, Schedule 13G, by FMR LLC | 19% of the class | 5%+ stakes | Source |
| August 8, 2025 | Stake report, Schedule 13G, by Arboretum Ventures VI, L.P. | 5.8% of the class | 5%+ stakes | Source |
| August 5, 2025 | Stake report, Schedule 13D, by Gilde Healthcare Holding B.V. | 11.8% of the class | 5%+ stakes | Source |
| August 1, 2025 | IPO filing, Form 424B4 | $15 a share | IPO filings | Source |
| July 25, 2025 | IPO filing, Form S-1/A | $19 to $21 a share | IPO filings | Source |
| July 24, 2025 | IPO filing, Form S-1/A | $19 to $21 a share | IPO filings | Source |
Selling to them or working with them? See who runs Shoulder Innovations, Inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on Shoulder Innovations, Inc. and the records around it.
The people at Shoulder Innovations, Inc.
- Robert Ball is also named on 1 other Form D filing: Capitan Orthopedics, Inc. (Jan 2026)
Shoulder Innovations, Inc. elsewhere on the record
- 5%+ stake filings Aug 2026
- IPO filing Aug 2025
- Form D filing Mar 2025
- Who owns it
Companies that share a holder
- Gilde Healthcare Holding B.V. also filed stake reports on 2 other companies: Mobia Medical, Inc. (May 2026), SpyGlass Pharma, Inc. (Feb 2026)
- U.S. Venture Partners XII, L.P. also filed stake reports on 2 other companies: Mobia Medical, Inc. (Aug 2026), Carlsmed, Inc. (Nov 2025)
- FMR LLC also filed stake reports on 762 other companies: ASPEN NEUROSCIENCE INC (Nov 2026), AVALO THERAPEUTICS INC (Nov 2026), BRAZE INC (Nov 2026)
Watch Shoulder Innovations, Inc.
Get an email when Shoulder Innovations, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Shoulder Innovations, Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Shoulder Innovations, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Shoulder Innovations, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
14 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
The newest 12 of 15 records.
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-03-10 | Out | Director | 8-K, 2026-03-10 | ||
| 2026-03-02 | In | Director | 8-K, 2026-03-02 |
Why did they leave? What the filings say
For each named departure below, the sentence from the company's own filing that gives a reason, word for word. Where a filing gives none, it says so here; nothing is inferred.
- Michael Carusi, Director (filed 2026-03-10):
Mr. Carusi's decision was not the result of any disagreement with the management or the Board on any matter relating to the Company's operations, policies or practices.
Who leads Shoulder Innovations, Inc., as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Director: Michael Carusi, departure reported (filed 2026-03-10). No successor is named in these filings.
New leaders reset buying decisions — get the Full Report on Shoulder Innovations, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Director at Shoulder Innovations, Inc., with the record behind each one.
Find candidates like Director at Shoulder Innovations, Inc.Every change, in the filing's words
Departing: Michael Carusi, Director
On March 6, 2026, Michael Carusi, a Class I director of the Company's Board of Directors ("Board"), notified the Company of his intention to not stand for re-election at the Company's at the 2026 Annual Meeting of Stockholders (the "Annual Meeting") upon the conclusion of his current term.
- Mr. Carusi's term with the Board will conclude effective on the date of the Annual Meeting.
Appointed: Andrew Hykes, Director
Director Appointment O n February 26, 2026, the Board appointed Andrew Hykes, age 53, as a Class I member of the Board and to serve as a member of the Compensation Committee, in each case effective immediately to fill the vacancy upon the resignation of Mr. Pardo.
- Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officer.
- Director Resignation O n February 26, 2026, G eoff Pardo notified the Board of Directors ("Board") of Shoulder Innovations, Inc. (the "Company") that he will resign as a Class I director of the Board, as a member of the Compensation Committee of the Board and as Chair of the Nominating and Corporate Governance Committee of the Board effective immediately.
- Mr. Pardo's decision to resign was not the result of any disagreement with the management or the Board on any matter relating to the Company's operations, policies or practices.
- Mr. Hykes will receive compensation under the Company's Non-Employee Director Compensation Program, which was previously filed with the Securities and Exchange Commission (the "SEC").
- Mr. Hykes will also enter into the Company's standard form of indemnification agreement for directors, which was previously filed with the SEC.
- Mr. Hykes has served as the President and Chief Executive Officer of Okami Medical, Inc., a medical device company committed to the development of innovative, versatile, and intuitive devices for the occlusion of peripheral vessels ("Okami"), since October 2025.
Tools for this story
Each opens in a new tab, filled in for Shoulder Innovations, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.
